INESSA MEYEROVICH: Open Payments
NPI 1619957404 · REGO PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,225 in 127 payments from 19 companies in 2025. Trend: 2023 $1,422 · 2024 $1,997 · 2025 $3,225
Food & beverage: $3,071Education: $154
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $554 |
| Teva Pharmaceuticals USA, Inc. | 17 | $413 |
| Otsuka America Pharmaceutical, Inc. | 14 | $343 |
| Aimmune Therapeutics, Inc. | 5 | $271 |
| Neurocrine BioSciences, Inc. | 10 | $267 |
| ABBVIE INC. | 10 | $230 |
| Vanda Pharmaceuticals Inc. | 8 | $210 |
| HARMONY BIOSCIENCES LLC | 7 | $186 |
| Alkermes, Inc. | 8 | $178 |
| Lundbeck LLC | 7 | $146 |
Products named: CAPLYTA, REXULTI, ZENPEP, INGREZZA, FANAPT, ARISTADA, UZEDY, VRAYLAR.
Industry payments across NY — which companies pay providers there.
